A detailed history of Triune Financial Partners, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Triune Financial Partners, LLC holds 2,292 shares of MRK stock, worth $231,858. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,292
Holding current value
$231,858
% of portfolio
0.08%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$111.15 - $128.97 $254,755 - $295,599
2,292 New
2,292 $260 Million
Q2 2024

Nov 05, 2024

SELL
$123.8 - $132.96 $1,733 - $1,861
-14 Reduced 0.61%
2,278 $282 Million
Q1 2024

Nov 14, 2024

BUY
$113.24 - $131.95 $1,925 - $2,243
17 Added 0.64%
2,665 $352 Million
Q4 2023

Nov 14, 2024

BUY
$100.18 - $109.02 $1,803 - $1,962
18 Added 0.68%
2,648 $289 Million
Q3 2023

Nov 14, 2024

BUY
$102.95 - $114.33 $34,797 - $38,643
338 Added 14.75%
2,630 $271 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $256B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Triune Financial Partners, LLC Portfolio

Follow Triune Financial Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Triune Financial Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Triune Financial Partners, LLC with notifications on news.